Report · techcrunch.com
Who’s really in charge at Anthropic after the IPO?

techcrunch.com
Source published October 27, 2026
Summary: 2 min read
0/100
Summary
Anthropic’s planned initial public offering would give public shareholders limited influence over major company decisions under a governance structure designed to preserve its AI-safety mission. Anthropic, founded in 2021 as a public benefit corporation, can legally weigh public benefits alongside profits, protecting board decisions on AI safety from shareholder-value-only challenges. A Long-Term Benefit Trust holds a special stock class that can elect and remove a majority of Anthropic’s directors. The trust is chaired by former GiveWell managing director Neil Shah and includes former Federal Reserve chair Ben Bernanke, national-security expert Richard Fontaine, and Harvard physicist Christopher Stubbs; it has one vacancy. Anthropic’s seven founders separately hold a stock class giving a majority of them 50.1% of shareholder voting power and the right to elect three board members. Daniela Amodei chairs the board, which also includes CEO Dario Amodei, Reed Hastings, Christopher Liddell, Vas Narasimhan, and Yasmin Razavi, with one vacant seat. The board’s nominating committee can reject certain trust appointments or no-cause removals and send the decision to employees for a vote. Founder control can end 10 years after the IPO by choice or automatically if fewer than three founders remain. The trust would continue until 85% of common shareholders vote to end it or it steps down with board approval.
Key Takeaways
- Anthropic’s Long-Term Benefit Trust can elect and remove a majority of the board through a special class of stock.
- Anthropic’s seven founders hold 50.1% of shareholder voting power and can elect three directors while their control remains in effect.
- Anthropic’s public benefit corporation status permits its board to consider AI safety and other public-benefit goals alongside profit.
- Employees can vote on certain board-seat disputes when Anthropic’s nominating committee rejects a Long-Term Benefit Trust action.
- Founder control can end 10 years after the IPO or automatically when fewer than three founders remain; ending the trust would require an 85% common-shareholder vote unless the trust steps down with board approval.
Coverage & discussions
RSS · TechCrunch AI · techcrunch.com
Related Articles

The obscure trust looming over Anthropic's IPO
Oct 19, 2026

Anthropic officially files for its public debut
Oct 26, 2026

Investing in the public benefit
Oct 18, 2026

Why Anthropic's filing crushed tech stocks
Oct 31, 2026

VCs will make billions on Anthropic’s IPO, but Amazon is set to make much (much) more
Oct 28, 2026